Question · asked by 1 review
Surgery plus radiotherapy vs Chemotherapy (chemoradiotherapy): Locoregional recurrence
- Population
- Adults with oral cavity or oropharyngeal cancer
- Intervention
- Surgery plus radiotherapy
- Comparison
- Chemotherapy (chemoradiotherapy)
- Outcome
- Locoregional recurrence
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Surgery plus adjuvant radiotherapy vs Chemotherapy (chemoradiotherapy) Locoregional recurrence · Adults with oral cavity or oropharyngeal cancer · oral cavity Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment (2023) · Cochrane All outcomes | Locoregional recurrence: reported difference between groups not statistically significant (P=0.355), but no useable data; 32 participants (1 RCT, Iyer 2015). | 1 study · 32 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment 2023 · Cochrane All outcomes | 2022-02 | Not listed | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Surgery plus radiotherapy vs Radiotherapy alone · Adults with oral cavity or oropharyngeal cancer · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.